CNBC's Mandy Drury and the Fast Money traders discuss the day's top trades and the stocks they'll be watching Wednesday.

CNBC's Seema Mody looks at the day's market action. Wilbur Ross, Chairman & CEO, WL Ross & Co. LLC, discusses the impact of ongoing quantitative easing on investors and stocks. With Joe LaVorgna, Deutsche Bank.

Jim Cramer has an idea for how Apple could spend some of its billions in cash and he thinks it's better than what investor David Einhorn is pushing (4:13)

Biotech Immunogen showed signs of life today after getting FDA approval of a new breast cancer treatment. Cramer talks to CEO Daniel Junius about the progress of the drug and when patients will see it in doctor's offices, as well as what it means to the company.

The Fast Money crew offers special CNBC.com-only advice on your investments.

Cramer looks at the S&P 500 technicals to determine whether the volatility means it's time to bail or get on board.

Mad Money host Jim Cramer says you can pay attention to Italy, but he has a different perspective. The days when Europe sneezed and the U.S. caught a cold are over, he says. The good economic news just keeps coming.

The Fast Money traders share their final trades of the day.

First Solar gets hammered after it doesn't give an outlook. Yesterday, the euro and dollar had more of a reaction than they did today. Today, for the most part, the euro and U.S. dollar traded sideways, which the Aussie dollar and Kiwi dollar fell heavily and gold spiked, with Amelia Bourdeau, Westpac Institutional.

Papa John's announces it should restate financials from 2009 to 2011. The VIX has surged more than 47 percent in the last week, just as the market re-approaches its all-time highs. Paul Hickey, Bespoke Investment Group, explains why this is a bad sign.

What to expect in tomorrow's trading, with Michael Underhill, Capital Innovations; Steven Rosen, Societe Generale; and Brian Peery, Hennessy Focus 30 Fund.

The S&P Case Shiller is reporting prices are up 6.9 percent annually for the top 20 housing markets, reports CNBC's Diana Olick. Greg Ip, The Economist, and Terry Duffy, CME Group, offer insight.

The Fast Money traders take a look at today's biggest market movers.

Dissecting the day's major business news, with the Fast Money traders. What's likely to happen with Apple? Will the company really offer a stock split? And Dennis Gartman, The Gartman Letter, offers his view on how investors should position themselves now.

Apple has "a history of dismissing investors' interests" in using its cash on hand, Karen Finerman of Metropolitan Capital Advisors says.

CME Group Executive Chairman Terry Duffy shares his opinions on market volume, and President Obama's nomination to chair the SEC, Mary Jo White.

Discussing recent trading action and how the Italian election and Bernanke's testimony impacted the markets, with Terry Duffy, CME Group executive chairman.

Priceline is reporting Q4 earnings per share of $6.77 ex-items and revenue of $1.19 billion, reports CNBC's Simon Hobbs.

CNBC's Josh Lipton looks at three stocks investors should keep their eye on tomorrow. Today, it's Priceline.com, Apple ahead of tomorrow's shareholder meeting, and retail giant Target.

Assessing today's market action amid the Italian election and after Fed Chief Ben Bernanke's testimony, with Terry Dolan, Benjamin & Jerold Brokerage. We've seen both fear and greed in the markets, he says.